Monkeypox Cases: Update as of September 15, 2022

Update as of September 15, 2022, following reports of monkeypox cases in France and around the world.

Download

In this article

In addition to the weekly updates, Public Health now provides open data on its Géodes website showing the total number of confirmed cases and the weekly number of new monkeypox cases.

Monitoring indicators now available as open data. To help everyone better understand the progression of the monkeypox epidemic, the agency is making the following data available as open data on Géodes:

  • Weekly number of new confirmed Monkeypox cases

  • Total number of confirmed Monkeypox cases

These indicators are available by date of reporting and broken down nationally and regionally into four age groups: under 15, 15–44, 45–64, 65 and older, and by gender.

Data for the calendar week will be updated every Wednesday.

Update on the Situation in France

As of 12:00 p.m. on September 15, 2022, 3,898 confirmed cases of locally transmitted Monkeypox infections had been recorded in France, representing 113 additional cases since the September 8 update. The breakdown of cases by region of residence (or by region of reporting when the region of residence is unknown) is as follows: 2,382 in Île-de-France, 309 in Occitanie, 266 in Provence-Alpes-Côte d’Azur, 252 in Auvergne-Rhône-Alpes, 189 in Hauts-de-France, 136 in Nouvelle-Aquitaine, 93 in Grand Est, 87 in Pays de la Loire, 44 in Normandy, 38 in Centre-Val de Loire, 37 in Brittany, 29 in Bourgogne-Franche-Comté, 7 in Martinique, and 5 in Corsica. Guadeloupe, Réunion, Mayotte, and Saint-Martin each reported 1 case, and 20 cases were residents abroad.

The vast majority of confirmed adult cases recorded to date are male, and 86 cases (2.2%) are female. Nine children under the age of 15 have been reported. Adult cases have a median age of 36; 25% of adult cases are under 29 years old, and 25% are between 43 and 81 years old.
The distribution of cases by date of symptom onset (when known) is shown in Figure 1. Due to reporting delays, data from recent weeks are not yet consolidated. Reports received do not always include the date of symptom onset. As an alternative to this information, the distribution of cases by date of reporting is shown in Figure 2.

Figure 1. Confirmed cases of monkeypox (n=2,797 cases, number of missing data points: 1,101) by week of symptom onset, France, May–September 2022 (data as of September 15, 2022 – 12:00 p.m.).

Figure 1. Cas confirmés de variole du singe (n=2 797 cas, nombre de données manquantes : 1 101) par semaine de début des symptômes, France, mai-septembre 2022 (données au 15/09/2022 – 12h00).
The data for the past few weeks (in light blue) is not yet fully finalized.

Figure 2. Confirmed cases of monkeypox (n=3,898 cases) by week of reporting, France, May–September 2022 (data as of September 15, 2022 – 12:00 p.m.).

Figure 2. Cas confirmés de variole du singe (n=3 898 cas) par semaine de signalement, France, mai-septembre 2022 (données au 15/09/2022 – 12h00).
The data for the past week (in light blue) is not yet fully consolidated.

Preventive vaccination against monkeypox

Regarding the rollout of the vaccination program, as of September 15, 2022, 157,952 doses of the third-generation vaccine had been delivered by the Agency to the territories.

As of September 14, 2022, the total number of doses administered is 94,228 (source: Ministry of Health and Prevention).

Information and Prevention Initiatives

Given what has been observed in Europe regarding the disease, targeted communication was quickly implemented for men who have sex with men (MSM). The website sexosafe.fr, dedicated to the sexual health of MSM, is regularly updated with a summary of current knowledge on the subject and prevention measures. Poster, radio, and digital campaigns provide information to the public, complementing on-the-ground efforts. Since June 17, the digital campaign has generated nearly 923,577 clicks on banners and over 813,837 visits to the Sexosafe website.

All information on vaccination is updated weekly on the page for the general public and the page for healthcare professionals (accessible without a login) on the Vaccination-info-service website.

Prevention efforts are continuously adapted to the evolving situation and the current state of knowledge.

To facilitate access to information for vulnerable people in precarious situations, a visual tool—translated into 8 languages and developed with professionals working with these individuals—is available on Santé publique France:

The MOBCO Newsletter No. 7, developed in collaboration with frontline workers, compiles a series of questions and answers on the topic of monkeypox. It is intended for professionals or volunteers in contact with people in precarious situations.

In France, ongoing surveillance of monkeypox through the mandatory reporting system has been strengthened, and information and alert messages are being sent to healthcare professionals. Discussions are also continuing with other European countries, the WHO, and the ECDC.

Monkeypox Info Service: A helpline to answer questions about monkeypox

The “Monkeypox Info Service” hotline is available daily from 8 a.m. to 11 p.m. at the toll-free number 0 801 90 80 69 (free calls and services; anonymous and confidential). This service is responsible for supporting prevention messages and protective measures, providing information on symptoms, treatments, and vaccination, and offering advice and referrals to care services.

Since the hotline opened in mid-July, 7,545 calls have been handled by the Monkeypox Info Service.